Barely Significant
← all excerpts

Monitoring response to anti-angiogenic mTOR inhibitor therapy in vivo using <sup>111</sup>In-bevacizumab.

EJNMMI Res · 2017 · PMC5449352 · PMID 28560583

Europe PMCDOI
1
hedged sentence
0.0700
closest p · 1.4× alpha
0.0700
boldest claim

The sentences

did not reach statistical significanceP = 0.07so close (0.05 < p ≤ 0.1)
6a ) (from 283 ± 56 to 419 ± 47 pg/g of protein) measured by ELISA; however, this did not reach statistical significance ( P = 0.07).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.